Welcome to our dedicated page for HALLIBURTON CO SEC filings (Ticker: HAL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on HALLIBURTON CO's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into HALLIBURTON CO's regulatory disclosures and financial reporting.
Halliburton Co. received an amendment to a Schedule 13G/A from Capital Research Global Investors reporting beneficial ownership of 8,651,999 shares, equal to 1.0% of the 835,397,735 shares believed to be outstanding.
The filing lists sole voting power of 8,651,990 and sole dispositive power of 8,651,999. The amendment is dated 06/30/2026 and signed on 07/01/2026.
Halliburton director Maurice S. Smith reported a new compensation award of 1,079.638 stock equivalent units linked to Halliburton common stock. These units were acquired at a stated price of $0.00 under the company’s Directors' Deferred Compensation Plan and convert to common shares on a one-for-one basis following cessation as a director.
The filing also lists existing awards of restricted stock units from 2023, 2024, and 2025, each representing the right to receive Halliburton common shares. Footnotes explain that stock equivalent units accrue from director fees and dividends, using closing prices of $38.63, $33.90, and $34.09 on specified dates.
Halliburton Company reported the death of Board member Mr. Abdulaziz F. Al Khayyal, who passed away on June 24, 2026 and whose death was reported to the company on June 25, 2026. He had served on the Halliburton Board of Directors since 2014.
Mr. Al Khayyal was a member of the Audit Committee and the Health, Safety and Environment Committee at the time of his death. The company described him as a distinguished director who will be greatly missed.
HALLIBURTON CO Executive Vice President and Chief Financial Officer Eric Carre reported an open-market sale of 24,778 shares of common stock at $35.89 per share on June 18, 2026. The sale was effected under a Rule 10b5-1 trading plan adopted on March 18, 2026.
Following this transaction, Carre directly holds 148,520.478 shares of Halliburton common stock, including 243.855 shares accumulated through dividend reinvestment as of June 22, 2026. He also holds stock options to buy 30,100 shares at $53.54 expiring December 7, 2026, 34,425 shares at $43.38 expiring December 6, 2027, and 50,100 shares at $31.44 expiring December 5, 2028.
Halliburton filed a Form 144 notice for proposed sales of Common Stock. The entry lists 24,778 shares and an aggregate dollar figure of $889,282.42 with an associated identifier 835397735 and date 06/18/2026. The excerpt also shows multiple issuer-side events labeled Restricted Stock Vesting and Dividend Reinvestment with share counts and dates in 2024 and 2025.
Halliburton Company held its Annual Meeting of Shareholders on May 20, 2026, where investors voted on directors, auditor ratification, executive pay, and several equity and governance plans. Each director nominee received substantially more votes "For" than "Against," so the full slate was elected.
Shareholders approved ratifying KPMG LLP as independent accountants with 674,149,410 votes for and 36,742,407 against. They also backed, on an advisory basis, Halliburton’s executive compensation, and approved amendments to the Halliburton Energy Services, Inc. charter, the Halliburton Company Stock and Incentive Plan, and the Employee Stock Purchase Plan.
Halliburton Company executive Van H. Beckwith reported an open-market sale of 198,349 shares of Common Stock. The shares were sold on May 15, 2026 at a weighted average price of $41.29 per share, across multiple trades between $41.15 and $41.38.
After this transaction, Beckwith directly holds 146,186.49 Halliburton shares. The sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on August 13, 2025, indicating the sales were scheduled in advance rather than timed discretionarily.
HAL filed a Form 144 reporting proposed sales of Common Stock under restricted stock vesting events and a recent sale. The filing lists restricted-stock vesting entries of 63,823, 83,347 and 51,179 shares with vesting dates of 01/15/2023, 02/27/2024 and 03/03/2025 respectively. It also records a sale by Van Beckwith of 19,618 shares on 03/16/2026 for $663,480.76.
Halliburton Company executive Michael Casey, President – Western Hemisphere, sold 20,348 shares of common stock in open-market transactions. The sales occurred on May 5, 2026 at prices of $42.00 and $41.84 per share and were effected under a Rule 10b5-1 trading plan adopted on February 3, 2026. A footnote also notes 656.906 shares previously purchased through the Halliburton Employee Stock Purchase Plan for the period ending March 31, 2026.